Oral Oncology
Volume 40, Issue 1 , Pages 103-106 , January 2004

Primary B-cell lymphoma of the tongue in a patient with systemic sclerosis

Received 12 June 2003 ,Accepted 13 June 2003.

References 

  1. Sigurgeirsson B, Lindelof B, Edhag O. Risk of cancer in patients with dermatomyositis and polymyositis. N Engl J Med. 1992;326:363–367
  2. Zufferey P, Meyer OC, Grossin M, et al.  Primary Sjögren's syndrome and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol. 1995;24:342–345
  3. Isomaki HA, Hakulinen T, Jout Senlahti U. Excess risk of lymphoma, leukemia and myeloma in patients with rheumatoid arthritis. Ann Rheum Dis. 1982;41:34–38
  4. Tuffanelli DL, Winkelmann RK. Systemic scleroderma (a clinical study of 727 cases). Arch Dermatol. 1961;84:359–371
  5. Abu Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum. 1993;36(4):460–464
  6. Rosenthal AK, McLaughlin JK, Linet MS, Persson I. Scleroderma and malignancy (an epidemiological study). Ann Rheum Dis. 1993;52:531–533
  7. Varga J, Haustein UF, Creech RH, Dwyer JP, Jimenez SA. Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA. 1991;265(24):3292–3295
  8. Warnke RA, Strauchen JA, Burke JS, et al.  Morphologic types of large-cell lymphoma. Cancer. 1982;50:690–695
  9. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma . The Non-Hodgkin's Lymphoma Classification project. Blood. 1997;89:3909–3918
  10. Otter R, Gerrits WBJ, Sandt MM, et al.  Primary extranodal and nodal non-Hodgkin's lymphoma: a survey of a population-based registry. Eur J Cancer Clin Oncol. 1989;25:1203–1210
  11. Sutcliffe SB, Gospodarowcz MK. Clinical features and management of localized extranodal lymphomas. In:  Keating A,  Armitage J,  Burnet A, et al. editor. Haematological oncology. Cambridge: Cambridge University Press; 1992;p. 189–223
  12. Jacobs C. Lymphomas of extranodal head and neck sites. Cancer Treat. Res. 1987;32:269–284
  13. Gridley G, Kippel JH, Hoover RN, et al.  Incidence of cancer among men with Felty's syndrome. Ann Intern Med. 1994;120:35–39
  14. Famularo G, Giacomelli R, Alesse E, et al.  Polyclonal B lymphocyte activation in progressive systemic sclerosis. J Clin Lab Immunol. 1989;29(2):59–63
  15. Kahan A, Kahan A, Menkes CJ, Amor B. Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis. Ann Rheum Dis. 1986;45(7):553–560

PII: S1368-8375(03)00137-4

doi: 10.1016/S1368-8375(03)00137-4

Oral Oncology
Volume 40, Issue 1 , Pages 103-106 , January 2004